mRNA-Lipid Nanoparticle COVID-19 Vaccines: Structure and Stability

Authors

  • Daan J. A. Crommelin Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands

DOI:

https://doi.org/10.33892/aph.2021.91.120

Keywords:

COVID-19, lipid nanoparticle (LNP), lyophilization, mRNA, shelf life, storage stability, structure, vaccine

Published

2021-11-15

How to Cite

(1)
Crommelin, D. J. A. MRNA-Lipid Nanoparticle COVID-19 Vaccines: Structure and Stability. Acta Pharm Hung 2021, 91, 120.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License